View of Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma

Return to Article Details Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma Download Download PDF